Dengue - the underestimated risk in travellers.

In recent decades, the incidence, distribution and clinical severity of dengue have increased dramatically in most tropical and subtropical areas worldwide. As a consequence, and due to the expanding international tourism, health care providers in European travel clinics are more and more confronted with dengue, reflecting its global impact. Based on data of the European Network on Imported Infectious Disease Surveillance (TropNetEurop) and the German Surveillance Network on Imported Infectious Diseases (SIMPID), a total of 483 confirmed and probable cases of dengue fever, including 13 cases of dengue haemorrhagic fever were reported to the networks’ coordination centre between January 1999 and December 2002. There was a wide range of epidemiological and clinical features. Non-European travellers (immigrants or foreign visitors) were at 4.3-times higher risk of developing dengue haemorrhagic fever compared to European travellers. Infections were acquired in all endemic regions of the world, with highest frequencies in South-East Asian countries. Persons travelling to areas where dengue is endemic should avoid exposure to mosquitoes, and health care providers should consider dengue as a differential diagnosis in febrile travellers returning from the tropics after discounting malaria. Surveillance of imported dengue is crucial to monitor the risk of infection for travellers and to strengthen clinical awareness of the disease.

[1]  D. Gubler,et al.  A dengue outbreak among camp participants in a Caribbean island, 1995. , 2007, Journal of travel medicine.

[2]  S. Lawn,et al.  Dengue hemorrhagic fever with fulminant hepatic failure in an immigrant returning to Bangladesh. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  T. John Dengue fever and dengue haemorrhagic fever , 2003, The Lancet.

[4]  S. McLellan,et al.  Evaluation of fever in the returned traveler. , 2002, Primary care.

[5]  N. Mühlberger,et al.  Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  C. Haritoglou,et al.  A tourist with dengue fever and visual loss , 2002, The Lancet.

[7]  W. Preiser,et al.  Travel-Acquired Dengue Infection: Clinical Spectrum and Diagnostic Aspects , 2002, Infection.

[8]  D. Vaughn,et al.  Dengue: an escalating problem , 2002, BMJ : British Medical Journal.

[9]  U. Thisyakorn,et al.  Dengue infection: a global concern. , 2002, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[10]  F. Cobelens,et al.  Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia , 2002, Tropical medicine & international health : TM & IH.

[11]  J. Lang,et al.  Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses. , 2002, The American journal of tropical medicine and hygiene.

[12]  N. Phuong,et al.  Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. , 2001, The American journal of tropical medicine and hygiene.

[13]  N. White,et al.  Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? , 2001, The Journal of infectious diseases.

[14]  S. Halstead,et al.  Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. , 2001, The American journal of tropical medicine and hygiene.

[15]  D. Vaughn,et al.  Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. , 2001, Vaccine.

[16]  E. Schwartz,et al.  Changing Epidemiology of Dengue Fever in Travelers to Thailand , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[17]  E. Mendelson,et al.  Evaluation of ELISA-based sero-diagnosis of dengue fever in travelers. , 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[18]  T. Jelínek,et al.  Dengue fever in international travelers. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  S. Wahid,et al.  A comparison of the pattern of liver involvement in dengue hemorrhagic fever with classic dengue fever. , 2000, The Southeast Asian journal of tropical medicine and public health.

[20]  N. Bhamarapravati,et al.  Live attenuated tetravalent dengue vaccine. , 2000, Vaccine.

[21]  C. Sirivichayakul,et al.  Dengue infection with unusual manifestations: a case report. , 2000, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[22]  I. Srugo,et al.  Dengue seroconversion among Israeli travelers to tropical countries. , 1999, Emerging infectious diseases.

[23]  E. Chungue,et al.  Dengue: an evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory‐confirmed cases , 1999, Tropical medicine & international health : TM & IH.

[24]  N. White Variation in virulence of dengue virus , 1999, The Lancet.

[25]  S. Halstead,et al.  Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever , 1999, The Lancet.

[26]  R. Rico-Hesse,et al.  Dengue Virus Structural Differences That Correlate with Pathogenesis , 1999, Journal of Virology.

[27]  F. Pinheiro,et al.  Re-emergence of dengue and emergence of dengue haemorrhagic fever in the Americas , 1997 .

[28]  T. Jelínek,et al.  Prevalence of infection with dengue virus among international travelers. , 1997, Archives of internal medicine.

[29]  A. Nisalak,et al.  Early clinical and laboratory indicators of acute dengue illness. , 1997, The Journal of infectious diseases.

[30]  A. Nisalak,et al.  Dengue in the early febrile phase: viremia and antibody responses. , 1997, The Journal of infectious diseases.

[31]  M. Aye,et al.  Risk factors in dengue shock syndrome. , 1997, The American journal of tropical medicine and hygiene.

[32]  E. Mendelson,et al.  Dengue fever among travelers. , 1996, The American journal of medicine.

[33]  R. López-Vélez,et al.  Dengue in Spanish travelers returning from the tropics , 1996, European Journal of Clinical Microbiology and Infectious Diseases.

[34]  C. Chansang,et al.  Dengue vector mosquitos at a tourist attraction, Ko Samui, in 1995. , 1996, The Southeast Asian journal of tropical medicine and public health.

[35]  P. Vernazza,et al.  [Imported dengue fever in Switzerland--serological evidence for a hitherto unexpectedly high prevalence]. , 1995, Swiss medical weekly.

[36]  S. Lam,et al.  Dengue haemorrhagic fever , 1995 .

[37]  T. Monath,et al.  Dengue: the risk to developed and developing countries. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Y. Liaw,et al.  Liver biochemical tests and dengue fever. , 1992, The American journal of tropical medicine and hygiene.

[39]  M. Guzmán,et al.  Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. , 1990, The American journal of tropical medicine and hygiene.

[40]  R. Rico-Hesse,et al.  Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. , 1990, Virology.

[41]  A. Nisalak,et al.  An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. , 1989, The American journal of tropical medicine and hygiene.

[42]  A. Nisalak,et al.  Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. , 1989, The American journal of tropical medicine and hygiene.

[43]  A. Nisalak,et al.  Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. , 1988, The American journal of tropical medicine and hygiene.

[44]  S. Halstead,et al.  Pathogenesis of dengue: challenges to molecular biology. , 1988, Science.

[45]  S. Nimmannitya Dengue haemorrhagic fever in Thailand. , 1987, The Southeast Asian journal of tropical medicine and public health.

[46]  S. Nimmannitya,et al.  Dengue haemorrhagic fever with unusual manifestations. , 1987, The Southeast Asian journal of tropical medicine and public health.

[47]  D. Gubler,et al.  Dengue shock syndrome in an American traveler with primary dengue 3 infection. , 1987, The American journal of tropical medicine and hygiene.

[48]  S. Halstead,et al.  Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. , 1984, American journal of epidemiology.

[49]  D. Gubler,et al.  Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. , 1978, The American journal of tropical medicine and hygiene.

[50]  L. Rosen,et al.  Fatal hemorrhagic disease and shock associated with primary dengue infection on a Pacific island. , 1974, The American journal of tropical medicine and hygiene.

[51]  M. Saeed,et al.  Dengue and Dengue Hemorrhagic Fever , 2015 .

[52]  B. Niklasson,et al.  Dengue fever among Swedish tourists. , 1993, Scandinavian journal of infectious diseases.

[53]  P. Thongcharoen Monograph on dengue/dengue haemorrhagic fever , 1993 .

[54]  A. Nisalak,et al.  A prospective study of dengue infections in Bangkok. , 1988, The American journal of tropical medicine and hygiene.